Jason M. Schenkel

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

37h-index12.9kcitations119works0.82yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(54), T-cell and B-cell Immunology(45), Cancer Immunotherapy and Biomarkers(42), Immunotherapy and Immune Responses(41), CAR-T cell therapy research(35)

Publications119 total

Lymph node resident memory T cells retain effector capabilities by evading lung resident memory dysfunction

2026Open Access

Primate resident memory T cells activate humoral and stromal immunity

2 cited

Immunity·2025· 2 cited

Abstract B001: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade

Cancer Immunology Research·2025

Abstract PR-10: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade

Cancer Immunology Research·2025

PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion

5 cited

The Journal of Experimental Medicine·2025· 5 citedOpen Access

Figure S2 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S6 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Table S4 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S5 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S8 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Data from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S7 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Table S3 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Table S2 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Table S1 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Table S5 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S4 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S3 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Figure S1 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

Table S6 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

2025Open Access

page 1 of 6Next →

Frequent Co-authors

David Masopust(19), Vaiva Vezys(12), Kathryn Fraser(11), Tyler Jacks(11), Lalit K. Beura(10), Andrew Zloza(10), Kristen E. Pauken(9), Peter M.K. Westcott(7), William L. Hwang(6), George Eng(6), William A. Freed-Pastor(6), Aviv Regev(6), Arjun Bhutkar(6), Frederick J. Kohlhapp(5), E. John Wherry(4), Emily A. Thompson(4), Michael S. Cuoco(4), Toni Delorey(4), Devan Phillips(4), Zackery A. Ely(4)